PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 46 filers reported holding PROQR THRAPEUTICS N V in Q2 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $281 | -71.9% | 76 | -92.3% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 987 | -21.9% | 0.00% | – |
| Q2 2022 | $1,000 | -90.0% | 1,263 | -88.8% | 0.00% | – |
| Q1 2022 | $10,000 | -92.1% | 11,314 | -28.8% | 0.00% | – |
| Q4 2021 | $127,000 | -48.2% | 15,899 | -45.7% | 0.00% | – |
| Q3 2021 | $245,000 | +6.5% | 29,284 | -14.3% | 0.00% | – |
| Q2 2021 | $230,000 | -98.2% | 34,175 | -98.2% | 0.00% | -100.0% |
| Q1 2021 | $12,464,000 | +65500.0% | 1,885,615 | +47468.5% | 0.01% | – |
| Q3 2020 | $19,000 | -20.8% | 3,964 | +2.5% | 0.00% | – |
| Q2 2020 | $24,000 | -38.5% | 3,869 | -45.7% | 0.00% | – |
| Q1 2020 | $39,000 | +2.6% | 7,124 | +86.1% | 0.00% | – |
| Q4 2019 | $38,000 | +533.3% | 3,828 | +274.2% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 1,023 | +13.3% | 0.00% | – |
| Q2 2019 | $8,000 | 0.0% | 903 | +53.3% | 0.00% | – |
| Q1 2019 | $8,000 | – | 589 | +14625.0% | 0.00% | – |
| Q3 2015 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |